A Open-label, Randomized, Single Dose, Crossover Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2019
Price : $35 *
At a glance
- Drugs Pregabalin (Primary)
- Indications Neurological disorders; Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Yuhan
- 14 Jan 2019 Status changed from recruiting to completed.
- 26 Jun 2017 Planned End Date changed from 30 Jun 2017 to 30 Oct 2017.
- 26 Jun 2017 Status changed from active, no longer recruiting to recruiting.